Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53-Reference-Cited by-同舟云学术

Differences in syncytia formation by SARS-CoV-2 variants modify host chromatin accessibility and cellular senescence via TP53

Published:2023-12 Issue:12 Volume:42 Page:113478
ISSN:2211-1247
Container-title:Cell Reports
language:en
Short-container-title:Cell Reports

Author:

Lee Jonathan D.^ORCID,Menasche Bridget L.,Mavrikaki Maria,Uyemura Madison M.,Hong Su Min,Kozlova Nina,Wei Jin,Alfajaro Mia M.,Filler Renata B.,Müller Arne,Saxena Tanvi,Posey Ryan R.,Cheung Priscilla,Muranen Taru,Heng Yujing J.,Paulo Joao A.,Wilen Craig B.,Slack Frank J.^ORCID

Funder

Richard and Susan Smith Family Foundation

National Institutes of Health

Beth Israel Deaconess Medical Center

National Institute of General Medical Sciences

Burroughs Wellcome Fund

Publisher

Elsevier BV

Subject

General Biochemistry, Genetics and Molecular Biology

Reference181 articles.

1. A Novel Coronavirus from Patients with Pneumonia in China, 2019;Zhu;N. Engl. J. Med.,2020

2. A new coronavirus associated with human respiratory disease in China;Wu;Nature,2020

3. Covid-19 Breakthrough Infections in Vaccinated Health Care Workers;Bergwerk;N. Engl. J. Med.,2021

4. Identification of a novel coronavirus in patients with severe acute respiratory syndrome;Drosten;N. Engl. J. Med.,2003

5. Isolation of a novel coronavirus from a man with pneumonia in Saudi Arabia;Zaki;N. Engl. J. Med.,2012

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Transfected SARS-CoV-2 spike DNA for mammalian cell expression inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells and increases cancer cell viability after chemotherapy exposure;Oncotarget;2024-05-03

2. SARS-CoV-2 spike S2 subunit inhibits p53 activation of p21(WAF1), TRAIL Death Receptor DR5 and MDM2 proteins in cancer cells;2024-04-15